Citi Raises Roivant Sciences (ROIV) PT to $35 Following Positive Phase 2 Brepocitinib Data

14 2 月, 2026

One Min Read

7 Views

原文: https://finance.yahoo.com/news/citi-raises-roivant-sciences-roiv-062936393.html

Last Update: 14 2 月, 2026

Written By

Other Articles

Previous

News Corporation (NWSA) PT Lowered to $39 from $40 by Citi

Next

Nothing opens its first retail store in India

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept